A prior report indicated that patients with CRC and high NCAPH expression have better prognoses because of their increased sensitivity to chemotherapy and/or irradiation [8], whereas NCAPH was identified as a potential candidate radioresistance gene in CRC [11]. This evidence concerns the gene NCAPH and colorectal carcinoma.